Advertisement

Cytokine Expression and Production Changes in Very Old Age

  • Susan E. McNerlan
  • Marilyn Armstrong
  • Owen A. Ross
  • I. Maeve Rea

Ageing is associated with various changes in immune parameters, alterations in lymphocyte subsets and cytokine dysregulation (Cossarizza et al. 1997). Cytokines are central to the regulation of the immune-inflammatory response in old age and so perhaps play a pivitol role in ageing and survival. But whether these alterations in cytokine expression and production are the secret of long life or are an indication of underlying disease, even in the apparently healthy, is uncertain. While studies of cytokine gene polymorphisms suggest that certain cytokine genotypes are associated with long life (Rea et al. 2006), cytokine levels have also been associated with various age-related diseases (Forsey et al. 2003). Studies of these parameters in very elderly subjects, i.e., those who have aged successfully, are perhaps the most useful in determining the key to longevity.

Keywords

Elderly Subject Young Control Human Longevity Cytokine Gene Polymorphism InCHIANTI Study 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alvarez V et al (2002) Association between the TNFalpha-308 A/G polymorphism and the onsetage of Alzheimer disease. Am J Med Genet 114:574PubMedCrossRefGoogle Scholar
  2. Baggiolini M et al (1992) Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett 307:97.PubMedCrossRefGoogle Scholar
  3. Barbieri M et al (2003) Chronic inflammation and the effect of IGF-I on muscle strength and power in older persons. Am J Physiol Endocrinol Metab 284:E481Google Scholar
  4. Bonafe M et al (2001) A gender-dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity. Eur J Immunol 31:2357PubMedCrossRefGoogle Scholar
  5. Bruunsgaard H et al (1999) A high plasma concentration of TNF-αis associated with dementia in centenarians. J Gerontol A Biol Sci Med Sci 54:M357–M364PubMedGoogle Scholar
  6. Bruunsgaard H et al (2000) Ageing, TNF-αand atherosclerosis. Clin Exp Immunol 121:255PubMedCrossRefGoogle Scholar
  7. Bruunsgaard H et al (2003a) Predicting death from tumour necrosis factor-alpha and interleukin-6 in 80 year old people. Clin Exp Immunol 132:24CrossRefGoogle Scholar
  8. Bruunsgaard H et al (2003b) Elevated levels of tumour necrosis factor alpha and mortality in centenarians. Am J Med 115:278CrossRefGoogle Scholar
  9. Carpurso C et al (2004) Interleukin 6-174G/C promoter gene polymorphism in centenarians: no evidence of association with human longevity or interaction with apolipoprotein E alleles. Exp Gerontol 39:1109CrossRefGoogle Scholar
  10. Carrieri G et al (2004) The G/C915 polymorphism of transforming growth factor-beta 1 is associated with human longevity: a study in Italian centenarians. Aging Cell 3:443PubMedCrossRefGoogle Scholar
  11. Caruso C et al (1996) Cytokine production pathway in the elderly. Immune Res 15:84CrossRefGoogle Scholar
  12. Catania A et al (1997) Cytokine antagonists in aged subjects and their relation with cellular immunity. J Gerontol A Biol Sci Med Sci 52A:B93–B97Google Scholar
  13. Cesari M et al (2004) Inflammatory markers and physical performance in older persons. The InCHIANTI Study. J Ger A Biol Sci Med Sci 59:242Google Scholar
  14. Cohen HJ et al (1997) The association of plasma IL-6 levels with functional disability in community dwelling elderly. J Ger A Biol Sci Med Sci 52:201Google Scholar
  15. Collins JS et al (2000) Association of a haplotype for tumour necrosis factor in siblings with lateonset Alzheimer disease. The NIMH Alzheimer Disease Genetics Initiative. Am J Med Genet 96:823PubMedCrossRefGoogle Scholar
  16. Cossarizza A et al (1997) Cytometric analysis of Immunosenescence. Cytometry 27:297PubMedCrossRefGoogle Scholar
  17. Di Iorio A et al (2003) Serum IL-1beta levels in health and disease: a population based study. ‘The InCHIANTI Study’. Cytokine 22:198PubMedCrossRefGoogle Scholar
  18. Ershler WB (1993) Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc 41:176PubMedGoogle Scholar
  19. Ershler WB, Keller ET (2000) Age-associated increased interleukin-6 gene expression, late-life diseases and frailty. Annu Rev Med 51:245PubMedCrossRefGoogle Scholar
  20. Forsey RJ et al (2003) Plasma cytokine profiles in elderly humans. Mech Ageing Dev 124:487PubMedCrossRefGoogle Scholar
  21. Franceschi C et al (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908:244PubMedCrossRefGoogle Scholar
  22. Frayling TM et al (2007) An interleukin-18 polymorphism is associated with reduced serum concentrations and better functioning in older people. J Gerontol A Biol Sci Med Sci 62:73PubMedGoogle Scholar
  23. Gangemi S et al (2003) Increased circulating interleukin-18 levels in centenarians with no sign of vascular disease: another paradox of longevity. Exp Gerontol 38:669PubMedCrossRefGoogle Scholar
  24. Gangemi S et al (2005) Age-related modifications in circulating IL-15 levels in humans. Mediators Inflamm 2005:245PubMedCrossRefGoogle Scholar
  25. Gerli R et al (2000) Chemokines, sTNF-Rs and sCD30 serum levels in healthy aged people and centenarians. Mech Ageing Dev 121:37PubMedCrossRefGoogle Scholar
  26. Gillis S et al (1981) Immunological studies of aging. Decreased production of and response to T cell growth factor by lymphocytes from aged humans. J Clin Invest 67:937PubMedCrossRefGoogle Scholar
  27. Giuliani N et al (2001) Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changes. Exp Gerontol 36:547PubMedCrossRefGoogle Scholar
  28. Harris TB et al (1999) Associations of elevated interleukin-6 and C-reative protein levels with mortality in the elderly. Am J Med 106:506PubMedCrossRefGoogle Scholar
  29. Jason J, Larned J (1997) Single cell cytokine profiles in normal humans: comparison of flow cytometric reagents and stimulation protocols. J Immunol Methods 207:13PubMedCrossRefGoogle Scholar
  30. Jordan WJ et al (2005) Human IL-19 regulates immunity through auto-induction of IL-19 production of IL-10. Eur J Immunol 35:1576PubMedCrossRefGoogle Scholar
  31. Jung T et al (1993) Detection of intracellular cytokines by flow cytometry. J Immunol Methods 159:197PubMedCrossRefGoogle Scholar
  32. Krabbe KS et al (2004) Inflammatory mediators in the elderly. Exp Gerontol 39:687PubMedCrossRefGoogle Scholar
  33. Liao YC et al (2002) IL-19 induces production of IL-6 and TNF-αand results in cell apoptosis through TNF-α. J Immunol 169:4288PubMedGoogle Scholar
  34. Lio D et al (2002) Gender specific association between -1082 IL-10 promoter polymorphism and longevity. Genes Immun 3:30PubMedCrossRefGoogle Scholar
  35. Lio D et al (2003) Inflammation, genetics and longevity: further studies on the prospective effects in men of IL-10—1082 promoter SNP and its interaction with TNF-alpha -308 promoter SNP. J Med Genet 40:296PubMedCrossRefGoogle Scholar
  36. Mattner F et al (1993) The interleukin-12 subunit p40 specifically inhibits effects of the interleukin- 12 heterodimer. Eur J Immunol 23:2202PubMedCrossRefGoogle Scholar
  37. McCusker SM et al (2001) Association between polymorphisms in regulatory region of gene encoding tumour necrosis factor αand risk of Alzheimer Disease and vascular dementia: a case-control study. Lancet 357:436PubMedCrossRefGoogle Scholar
  38. McNerlan SE et al (1997) TNF-αproduction from monocyte monolayers is increased in old age. Immunology 92(Suppl 1):107 (Abstract)Google Scholar
  39. McNerlan SE et al (2002) A whole blood method for measurement of intracellular TNFα, IFNγand IL-2 expression in stimulated CD3+ lymphocytes: differences between young and elderly subjects. Exp Gerontol 37:227PubMedCrossRefGoogle Scholar
  40. Mosmann TR, Sad S (1996) The expanding universe of T cell subsets, Th1, Th2 and more. Immunol Today 17:138PubMedCrossRefGoogle Scholar
  41. Nilsson J et al (1998) Relation between plasma tumour necrosis factor-αand insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 18:1199PubMedGoogle Scholar
  42. Okayama N et al (2007) Association of interleukin-19 gene polymorphisms with age. J Gerontol A Biol Sci Med Sci 62A:507Google Scholar
  43. O’Mahoney L et al (1998) Quantitative intracellular cytokine measurement: age-related changes in proinflammatory cytokine production. Clin Exp Immunol 113:213CrossRefGoogle Scholar
  44. Pes GM et al (2004) Association between longevity and cytokine gene polymorphisms. A study in Sardinian centenarians. Ageing Clin Exp Res 16:244Google Scholar
  45. Pietschmann P et al (2003) The effect of age and gender on cytokine production by human peripheral blood mononuclear cells and markers of bone metabolism. Exp Gerontol 38:1119PubMedCrossRefGoogle Scholar
  46. Prussin C, Metcalfe DD (1995) Detection of intracytoplasmic cytokines using flow cytometry and directly conjugated anti-cytokine antibodies. J Immunol Methods 188:117PubMedCrossRefGoogle Scholar
  47. Rea IM et al (1995) Increased IL-6 production from monocyte monolayers in octogenarian and nonagenarian subjects. Immunol 86(Suppl 1):58 (abstract)Google Scholar
  48. Rea IM et al (1996a) IL-10 production from monocyte monolayers in very old age. Immunology 89(Suppl 1):68 AbstractGoogle Scholar
  49. Rea IM et al (1996b) Changes in lymphocyte subsets, interleukin 2 and soluble interleukin 2 receptor in old and very old age. Gerontology 42:69CrossRefGoogle Scholar
  50. Rea IM et al (1999) CD69, CD25 and HLA-DR activation antigen expression on CD3+ lymphocytes and relationship to serum TNF-α, IFN-γand sIL-2R levels in ageing. Exp Gerontol 34:79PubMedCrossRefGoogle Scholar
  51. Rea IM et al (2000) Serum IL-12 and IL12p40 but not IL-12p70 are increased in the serum of older subjects: relationship to CD3+ and NK subsets. Cytokine 12:156PubMedCrossRefGoogle Scholar
  52. Rea IM et al (2003) Interleukin-6-gene C/G 174 polymorphism in nonagenarian and octogenearian subjects in the BELFAST study. Reciprocal effects on IL-6, soluble IL-6 receptor and for IL-10 in serum and monocyte supernatants. Mech Ageing Dev 124:555PubMedCrossRefGoogle Scholar
  53. Rea IM et al (2006) Longevity. In: Vandenbroeck K (ed) Cytokine gene polymorphisms in multifactorial conditions. CRC Press, p 379Google Scholar
  54. Rink L et al (1998) Altered cytokine production in the elderly. Mech Ageing Dev 102:199PubMedCrossRefGoogle Scholar
  55. Ross OA et al (2003a) Study of age-association with cytokine gene polymorphisms in an aged Irish population. Mech Ageing Dev 124:199CrossRefGoogle Scholar
  56. Ross OA et al (2003b) HLA haplotypes and TNF polymorphism do not associate with longevity in the Irish. Mech Ageing Dev 124:563CrossRefGoogle Scholar
  57. Roubenoff R et al (1998) Monocyte cytokine production in an elderly population: effect of age and inflammation. J Ger A Biol Sci Med Sci 53:M20–M26Google Scholar
  58. Sandmand M et al (2002) Is ageing associated with a shift in the balance between Type 1 and Type 2 cytokines in humans. Clin Exp Immunol 127:107PubMedCrossRefGoogle Scholar
  59. Sandmand M et al (2003) High circulating levels of TNF-αin centenarians is not associated with increased production in T-lymphocytes. Gerontol 49:155CrossRefGoogle Scholar
  60. Seckinger P et al (1989) Pruification and biological characterisation of a specific TNFαinhibitor. J Biol Chem 264:11966PubMedGoogle Scholar
  61. Summers AM et al (2000) Association of IL-10 genotype with sudden infant death syndrome. Hum Immunol 61:1270PubMedCrossRefGoogle Scholar
  62. Tortorella C et al (2002) APC-dependent impairment of T cell proliferation in aging: role of CD28- and IL-12/IL-15-mediated signalling. Mech Ageing Dev 123:1389PubMedCrossRefGoogle Scholar
  63. Trinchieri G (1993) Interleukin-12 and its role in the generation of Th1 cells. Immunol Today 14:335PubMedCrossRefGoogle Scholar
  64. Visser M et al (2002) Relationship of interleukin-6 and tumour necrosis factor-αwith muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci 57:M326–M332PubMedGoogle Scholar
  65. Volpato S et al (2001) Cardiovascular disease, interleukin-6 and risk of mortality in older women: the women’s health and aging study. Circulation 103:947PubMedGoogle Scholar
  66. Wang XY et al (2001) Lack of association between human longevity and polymorphisms of IL-1 cluster, IL-6, IL-10 and TNF-alpha genes in Finnish nonagenarians. Mech Ageing Dev 123:29PubMedCrossRefGoogle Scholar
  67. Westendorp RG et al (1997) Genetic influence on cytokine production in meningococcal disease. Lancet 348:1912CrossRefGoogle Scholar
  68. Wei J et al (1992) Increase of plasma IL-6 concentration with age in healthy subjects. Life Sci 51:1953PubMedCrossRefGoogle Scholar
  69. Wieczorowska-Tobis K et al (2006) Can an increased level of circulating IL-8 be a predictor of human longevity? Med Sci Monit 12:CR118–CR121Google Scholar
  70. Zanni F et al (2003) Marked increase with age of type 1 cytokines within memory and effector/ cytotoxic CD8+ T cells in humans: a contribution to understand the relationship between inflammation and immunosenescence. Exp Gerontol 38:981PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2009

Authors and Affiliations

  • Susan E. McNerlan
    • 1
  • Marilyn Armstrong
    • 2
  • Owen A. Ross
    • 3
  • I. Maeve Rea
    • 1
  1. 1.Department of Geriatric Medicine School of Medicine Dentistry and Biomedical SciencesQueen’s UniversityBelfastUK
  2. 2.School of Medicine Dentistry and Biomedical SciencesQueen’s UniversityBelfast
  3. 3.Mayo ClinicJacksonvilleUSA

Personalised recommendations